TANABE Akiko 田辺晃子

Researcher Number	70454543
Other IDs
Affiliation (based on the past Project Information) *help	2014 – 2019: 大阪医科大学, 医学部, 非常勤講師 2015: 大阪医科大学, 医学部, 助教 2014 – 2015: 大阪医科大学, 医学部, その他 2012 – 2015: 大阪医科大学, 医学部, 講師 2007 – 2012: 大阪医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology
Keywords	Principal Investigator 抗がん剤 / 上皮性卵巣癌 / 抗癌剤耐性 / Akt-mTOR-HIF / VEGF / EMT / GPR30 / EGFR / CD24 / snail … More Except Principal Investigator 卵巣癌 / EMT / CD24 / 子宮内膜癌 / 高分子ミセル / GPR30 / E-cadherin / 癌幹細胞 / 癌 / シスプラチン / 上皮間葉形質転換 / 薬剤耐性 / 浸潤・転移 / Snail / 婦人科癌 / EMT現象 / 婦人科悪性腫瘍 / ミセル / HGF / Met / 上皮間葉形態転換 / MET / 子宮頚癌 / マイクロRNA / エキソソーム / miRNA / マイクロアレイ / 薬剤反応性 / シグナル伝達 / トランスレーショナルリサーチ / タキソール / アポトーシス / プロモーターマイクロアレイ / NFkB / SiRNA / IAPファミリー / アデノウイルス / 耐性卵巣癌 / 分子標的治療 / イレッサ / 婦人科腫瘍学 / 抗血管新生治療 / 維持療法 / 生殖医学 / ミトコンドリア / 不妊症 / 顆粒膜細胞 / 抗ミュラー管ホルモン(AMH) / AMHレセプタ / 一塩基多型(SNP) / mtDNA4677 / real time PCR / 妊馬血ゴナドトロピン / ラットの顆粒膜細胞 / IVF-ET / hMG / recFSH / snail / slug / プロゲステロン受容体 / 幹細胞 / E-chadherin / Epithelial Mesenchymal Transition / E-cadherino / Slug / CD24, 婦人科悪性腫瘍 / EMT, 高分子ミセル / 抗癌剤耐性 / 白金製剤耐性卵巣癌 / EGFR / ABC transporter / ﾐｾﾙ / Foretinib / 明細胞腺癌 / ＡＭＨ / AMH: 146 T>G / -482 A>G / IVS1+149 T>A / IVS5-6 C>T / ＡＭＨＲ / 抗ミュウラー管ホルモン / 子宮内膜症 / 不妊 / 体外受精 / 一塩基多型 / ＳＮＰ / AMH　１４６T>G / AMHRII+１４９　T>A / ISV10+77　A>G / ISV５−６　C>T / Genotyping assay / c-myc / MYCBP / c-Myc / 腹膜播種 / MMT / 中皮―間葉転換 / 中皮-間葉転換 / ドラッグデリバリー / 腹膜播種転移 / 卵巣がん / drug delivery system / colony formation / シスプラチン耐性 / 抗癌剤 / 耐性 / 早期発見 / 癌微小環境 / microRNA / mi RNA / exosome / エクソソーム / lipid raft / 化学療法抵抗性 / ＣＤ２４ / ＥＭＴ / ＧＰＩアンカー型タンパク質 / ラフト形成 / ＧＰＩアンカー型蛋白質 / 癌関連繊維芽細胞 / 子宮体がん / 肥満 / 腫瘍随伴マクロファージ / 脂肪細胞 / FABP4 / がん関連繊維芽細胞 / がん / アディポカイン / がん微小環境 / ドラッグデリバリーシステム / 上皮・間葉形態転換 / ニッチ / Endothelinー2 / BNCT / 子宮頸癌 / 子宮頸がん / 硼素化合物 / 硼素内包高分子ミセル Less

Research for cancer microenvironment via FABP4 in endometrial cnacer
- Principal Investigator
  
  Sasaki Hiroshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Treatment strategy of boron neutron capture therapy in cervical cancer
- Principal Investigator
  
  Tsunetoh Satoshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- Principal Investigator
  
  Terai Yoshito
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kobe University
  Osaka Medical College
A novel approach for cervical cancer using exosome
- Principal Investigator
  
  Hayashi Masami
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer
- Principal Investigator
  
  Tanaka Yoshimichi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian ToxicityPrincipal Investigator
- Principal Investigator
  
  Tanabe Akiko
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer
- Principal Investigator
  
  Fujiwara Satoe
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.
- Principal Investigator
  
  SASAKI HIROSHI
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analyzing the possible involvement of anti-Müllerian hormon and anti-Müllerian hormon receptor II single nucleotide polymorphism in infertility
- Principal Investigator
  
  Yamashita Yoshiki
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Potential therapeutic target of microRNA in cervical cancer.
- Principal Investigator
  
  Masami Hayashi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Elucidation of novel molecules involved in the MET and disseminated in ovarian cancer peritoneal metastasis
- Principal Investigator
  
  KANEMURA MASANORI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells
- Principal Investigator
  
  TERAI YOSHITO
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.Principal Investigator
- Principal Investigator
  
  TANABE Akiko
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.
- Principal Investigator
  
  TSUNETOH Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
EMT including cancer stem cells regulates invasion and metastasis of uterine endometrial cancer.
- Principal Investigator
  
  TERAI Yoshito
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Developing of polymeric micelle for molecular targeting to cancer stem cells in ovarian cancer patients.
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analyzing how defects of Mitochondria DNA affect oocyte maturation.
- Principal Investigator
  
  YAMASHITA Yoshiki
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of the role of MPA as a molecular-targeted therapy in endometrial cancer.
- Principal Investigator
  
  KANEMURA Masanori
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Basic research of cancer stem cell for therapeutic target in cisplatin-resistant ovarian cancer.Principal Investigator
- Principal Investigator
  
  TANABE Akiko
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Basic research of either bevacizumab or gefitinib in platinum-resistant ovarian cancer.
- Principal Investigator
  
  TERAI Yoshito
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of chemo-resistance genes with promoter micro-array in ovarian cancer
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2006 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College

All 2017 2015 2014 2013 2012 2011 2010 2009 2008 Other

All Journal Article Presentation

[Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways2017
- Author(s)
  Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: - Pages: 3189-3200
- DOI
  10.3892/or.2017.5583
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
[Journal Article] Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines.2015
- Author(s)
  Ono YJ, Tanabe A, Tanaka T, Tanaka Y, Hayashi M, Terai Y, Ohmichi M.
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 14 Pages: 2353-2363
- DOI
  10.1158/1535-7163.mct-15-0187
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.2015
- Author(s)
  Tanaka T, Terai Y, Kogata Y, Ashihara K, Maeda K, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: 34 Pages: 2282-2288
- DOI
  10.3892/or.2015.4257
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] rosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.2015
- Author(s)
  Takai M, Nakagawa T, Tanabe A, Terai Y, Ohmichi M, Asahi M.
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 16(2) Pages: 325-335
- DOI
  10.1080/15384047.2014.1002362
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25460397, KAKENHI-PROJECT-25670709
[Journal Article] Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.2015
- Author(s)
  Watanabe A, Tanabe A, Maruoka R, Nakamura K, Hatta K, Ono YJ, Terai Y, Ohmichi M.
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 0 Pages: 0-0
- DOI
  10.1007/s10147-014-0779-y
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592535
[Journal Article] Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum.2015
- Author(s)
  Ono YJ, Hayashi M, Tanabe A, Hayashi A, Kanemura M, Terai Y, Ohmichi M.
- Journal Title
  
  American Journal of Physiology-Endocrinology and Metabolism
  
  Volume: Apr 7
- DOI
  10.1152/ajpendo.00573.2014
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24390384, KAKENHI-PROJECT-25462619, KAKENHI-PROJECT-25462620, KAKENHI-PROJECT-25670709
[Journal Article] Decorin induced by progesterone plays a crucial role in suppressing endometriosis.2014
- Author(s)
  Ono YJ, Terai Y, Tanabe A, Hayashi A, Hayashi M, Yamashita Y, Kyo S, Ohmichi
- Journal Title
  
  J Endocrinol
  
  Volume: 223 Pages: 203-216
- DOI
  10.1530/joe-14-0393
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24390384
[Journal Article] Postmenopausal patients with endometrial cancer of type 1 have elevated serum estradiol levels in the ovarian vein2014
- Author(s)
  Ashihara K, Tanaka T, Maruoka R, Ono YJ, Tanabe A, Terai Y, Ohmichi M
- Journal Title
  
  Int J Gynecol Cancer.
  
  Volume: 24 Pages: 1455-1460
- DOI
  10.1097/igc.0000000000000227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24390384
[Journal Article] Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.2014
- Author(s)
  Kawaguchi H, Terai Y, Tanabe A, Sasaki H, Takai M, Fujiwara S, Ashihara K, Tanaka Y, Tanaka T, Tsunetoh S, Kanemura M, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 7 Pages: 38-38
- DOI
  10.1186/1757-2215-7-38
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.2014
- Author(s)
  Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 76 Pages: 1-5
- DOI
  10.1186/1757-2215-7-76
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592536, KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.2013
- Author(s)
  anaka Y, Terai Y (分担) , Kawaguchi H, Fujiwara S, Yoo S, Tsunetoh S, Takai M, Kanemura M(分担), Tanabe A(分担), Ohmichi M (代表).
- Journal Title
  
  Cancer Biology and Therapy
  
  Volume: 14(1) Pages: 13-19
- Data Source
  KAKENHI-PROJECT-22659303
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.2013
- Author(s)
  Yoshimichi Tanaka
- Journal Title
  
  Cancer biology and therapy
  
  Volume: 14(1) Pages: 13-16
- DOI
  10.4161/cbt.22625
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591869, KAKENHI-PROJECT-24390384
[Journal Article] impact of EMT(Epithelial-Mesenchymal-Transition)related protein expression in endometrial cancer.2013
- Author(s)
  Tanaka Y, Terai Y*, Yoo S, Tsunetoh S, Kanemura M, Tanabe A, Ohmichi M. Prognostic
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 14(1) Pages: 13-9
- Data Source
  KAKENHI-PROJECT-22591869
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-relatedprotein expression in endometrial cancer.2013
- Author(s)
  Yoshimichi Tanaka, Yoshito Terai, Hiroshi Kawaguchi, Satoe Fujiwara, Saha Yoo, Satosi Tsunetoh, Masaaki Takai, Masanori Kanemura, Akiko Tanabe, Masahide Ohmichi
- Journal Title
  
  Cancer Biology and Therapy
  
  Volume: 14 Pages: 13-16
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.2012
- Author(s)
  Fujiwara S, Terai Y(分担)、Kawaguchi H, Takai M, Yoo S, Tanaka Y, Tanaka T,Tsunetoh S, Sasaki H (分担)、Kanemura M (分担)、Tanabe A (分担)、Ohmichi M (代表)
- Journal Title
  
  Journal of Ovarian Research
  
  Volume: 5(1) Pages: 35-44
- Data Source
  KAKENHI-PROJECT-22659303
[Journal Article] Impact of platinum-based chemotherapy on the progression of atherosclerosis2011
- Author(s)
  Sekijima T, Tanabe A, . Maruoka R, Fujishiro N, Fujiwara S, Yuguchi Y, Yamashita Y, Terai Y and Ohmichi M.
- Journal Title
  
  Climacteric
  
  Volume: 14 Pages: 31-40
- Data Source
  KAKENHI-PROJECT-21592117
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer2011
- Author(s)
  Yoshimichi Tanaka, Yoshito Terai, Akiko Tanabe, Hiroshi Sasaki, Tatsuharu Sekijima, Satoe Fujiwara, Yoshiki Yamashita, Masanori Kanemura, Masatsugu Ueda, Michio Sugita, Wilbur A. Franklin and Masahide Ohmichi
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 11 Pages: 50-57
- Data Source
  KAKENHI-PROJECT-21592117
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2011
- Author(s)
  Tanaka Y, Terai Y*, Tanabe A, Sasaki H, Sekijima T, Fujiwara S, Yamashita Y, Kanemura M, Ueda M, Sugita M, Franklin WA, Ohmichi M.
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 11 Pages: 50-57
- Data Source
  KAKENHI-PROJECT-22591869
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer2011
- Author(s)
  Tanaka Y, Tanabe A
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 11巻 Pages: 50-57
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592149
[Journal Article] Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulose cells?2011
- Author(s)
  Karita M, Yamashita Y, Hayashi A, Yoshida Y, Hayashi M, Yamamoto H, Tanabe A, Terai Y, Ohmichi M
- Journal Title
  
  Fertility and Sterility
  
  Volume: 95 Pages: 889-894
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592117
[Journal Article] Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulose cells?2011
- Author(s)
  Karita M, Yamashita Y, Hayashi A, Yoshida Y, Hayashi M, Yamamoto H, Tanabe A, Terai Y and Ohmichi M.
- Journal Title
  
  Fertil Steril
  
  Volume: 95 Pages: 889-894
- Data Source
  KAKENHI-PROJECT-21592117
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer2011
- Author(s)
  Tanaka Y, Tanabe A, et al
- Journal Title
  
  Cancer Biol.Ther.
  
  Volume: 11 Pages: 50-57
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592149
[Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.2010
- Author(s)
  Tsunetoh S, Tanabe A, Ohmichi M., et al
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 10 Pages: 1137-1146
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592149
[Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers2010
- Author(s)
  Tsunetoh S, Terai Y, Sasaki H, Tanabe A, Tanaka Y, Sekijima T, Fujioka S, Kawaguchi H, Kanemura M, Yamashita Y, Ohmichi M
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 10 Pages: 1137-114
- Data Source
  KAKENHI-PROJECT-21592117
[Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.2010
- Author(s)
  Tsunetoh S, Tanabe A, Ohmichi M, et al
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 10 Pages: 1137-1146
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22659303
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2010
- Author(s)
  Tanaka Y, Tanabe A, Ohmichi M., et al
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 11 Pages: 50-57
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592149
[Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2010
- Author(s)
  Tanaka Y, Tanabe A, Ohmichi M, et al
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 11 Pages: 50-57
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22659303
[Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers2010
- Author(s)
  Tsunetoh S, Tanabe A
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 10巻 Pages: 1137-1146
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21592149
[Journal Article] 難治性卵巣癌の分子標的治療の可能性2009
- Author(s)
  田辺晃子
- Journal Title
  
  大阪医科大学雑誌
  
  Volume: 68 Pages: 195-196
- Data Source
  KAKENHI-PROJECT-22659303
[Journal Article] Maintenance treatment with bevacizumab prolong survival in an in vivo ovarian cancer model.2008
- Author(s)
  Mabuchi S, Terai Y, Morishige K, Kimura-Tanabe A, Sasaki H, Kanemura M, Tsunetoh S, Tanaka Y, Sakata Y, Burger R, Kimura T, Ohmichi M.
- Journal Title
  
  Clin Cancer Res 14(23)
  
  Pages: 7781-7789
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] シスプラチン内包CD24高分子ミセルの開発とマウス難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原　敬允、田中　良道、田中　智人、佐々木　浩、恒遠　啓示、田辺　晃子、金村　昌徳、寺井　義人、大道　正英
- Organizer
  第67回日本産科婦人科学会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第14回日本婦人科がん分子標的研究会
- Place of Presentation
  松本市
- Year and Date
  2015-07-18
- Data Source
  KAKENHI-PROJECT-25462621
[Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第14回日本婦人科がん分子標的研究会
- Place of Presentation
  美ヶ原温泉ホテル翔峰
- Year and Date
  2015-07-17
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] 婦人科悪性腫瘍に対する抗癌剤治療が動脈硬化へ及ぼす影響とフィブラートの予防効果について2013
- Author(s)
  渡辺綾子、田辺晃子、丸岡寛、斉藤奈津穂、澤田雅美、丸岡理紗、中井香奈、中村起代子、中村路彦、寺井義人、大道正英
- Organizer
  第６５回日本産婦人科学会学術集会
- Place of Presentation
  北海道ロイトン札幌
- Data Source
  KAKENHI-PROJECT-24592535
[Presentation] 上皮間葉転換を介した浸潤・転移の制御を目指して2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第65回日本産科婦人科学会
- Place of Presentation
  北海道　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 若年性子宮内膜癌・子宮内膜異形増殖症に対するMPA治療法の治療成績2013
- Author(s)
  田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第51回日本癌治療学会
- Place of Presentation
  京都　京都国際会館
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 子宮頚癌におけるCD24の発現意義2013
- Author(s)
  田中智人、寺井義人、川口浩史、中村路彦、高井雅聡、兪史夏、藤原聡枝、田中良道、恒藤啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  日本癌治療学会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-25462619
[Presentation] 卵巣癌におけるEMT現象の意義2013
- Author(s)
  高井雅聡、寺井義人、川口浩史、中村路彦、兪史夏、藤原聡枝、田中智人、田中良道、恒遠啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 上皮間葉転換(EMT)を介した浸潤・転移の制御を目指して～CD24の機能解析～2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第６５回日本産科婦人科学会
- Place of Presentation
  北海道　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] The protective effect of fibrate against endothelial dysfunction induced by platinum-based chemotherapy in gynecological cancer patients2013
- Author(s)
  Ayako Watanabe, Akiko Tanabe, Risa Maruoka, Kiyoko Nakamura, Masaaki Takai, Yoshito Terai, Masahide Ohmichi
- Organizer
  The 5th scientific meeting of the asia pacific menopause federation
- Place of Presentation
  東京　京王プラザホテル
- Data Source
  KAKENHI-PROJECT-24592535
[Presentation] 白金製剤耐性卵巣癌におけるAktをターゲットとした分子標的薬としてのGemicitabineの機能解析2013
- Author(s)
  川口浩史、寺井義人、恒遠啓示、佐々木浩、高井雅聡、兪史夏、藤原聡枝、田中智人、田中良道、田辺晃子、金村昌徳、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 上皮間葉転換(EMT)を介した浸潤・転移の制御を目指して　～CD24の機能解析～2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 子宮体癌における EMT のマーカーとしての CD24 の有用性2012
- Author(s)
  田中良道、寺井義人、斎藤奈津穂、川口浩史、中村路彦、兪史夏、藤原聡枝、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第64回日本産科婦人科学会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-22591869
[Presentation] prognostic impact of EMepithelial-mesenchymal-transition)re lated protein expression in endometrial cancer2012
- Author(s)
  田中良道、寺井義人、川口浩史、高井雅聡、藤原聡枝、兪史夏、恒遠啓示、佐々木浩、金村昌徳、田辺晃子、大道正英
- Organizer
  2012 AmericanAssociation for Cancer Research
- Place of Presentation
  Chicago、USA
- Data Source
  KAKENHI-PROJECT-22591869
[Presentation] 婦人科癌と EMT(epithelial mesenchymal transition)」Frontiers in Gynecologic Oncology2011
- Author(s)
  寺井義人、田中良道、川口浩史、兪史夏、藤原聡枝、高井雅聡、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第50回日本婦人科腫瘍学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-22591869
[Presentation] 婦人科癌とEMT2011
- Author(s)
  寺井義人、田辺晃子
- Organizer
  第50回日本婦人科腫瘍学会学術集会
- Place of Presentation
  北海道
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 卵巣癌におけるエストロゲン受容体GPR30およびER/PRの発現と臨床病理学的意義2011
- Author(s)
  藤原聡枝、田辺晃子
- Organizer
  第63回日本産婦人科学会学術講演会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 卵巣癌におけるエストロゲン受容体GPR30およびER/PRの発現と臨床病理学的意義2011
- Author(s)
  藤原聡枝、田辺晃子, et al
- Organizer
  第52回日本臨床細胞学会総会
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 子宮体癌におけるE-cadherin, snail, slugの発現意義2010
- Author(s)
  日中良道、田辺晃子、大道正英
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  国立京都国際会館
- Year and Date
  2010-10-28
- Data Source
  KAKENHI-PROJECT-21592148
[Presentation] 卵巣癌におけるGPR30とEGFRの免疫組織化学的検討2010
- Author(s)
  藤原聡枝、田辺晃子、大道正英
- Organizer
  第62回日本産婦人科学会学術講演会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2010-04-23
- Data Source
  KAKENHI-PROJECT-22659303
[Presentation] 卵巣癌におけるGPR30の免疫組織化学的検討2010
- Author(s)
  藤原聡枝、田辺晃子、大道正英
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  国立京都国際会館
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 卵巣癌におけるGPR30とEGFRの免疫組織化学的検討2010
- Author(s)
  藤原聡枝、田辺晃子、大道正英
- Organizer
  第62回日本産婦人科学会学術講演会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2010-04-23
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 卵巣癌におけるEGFR遺伝子変異とその下流シグナル分子の発現解析2010
- Author(s)
  田中良道、田辺晃子、大道正英
- Organizer
  第62回日本産婦人科学会学術講演会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2010-04-23
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 卵巣癌におけるEGFR遺伝子変異とその下流シグナル分子の発現解析2010
- Author(s)
  田中良道、田辺晃子、大道正英
- Organizer
  第62回日本産婦人科学会学術講演会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2010-04-23
- Data Source
  KAKENHI-PROJECT-22659303
[Presentation] 卵巣癌におけるGPR30の免疫組織化学的検討2009
- Author(s)
  藤岡聡枝, 田辺晃子, 大道正英
- Organizer
  第47回日本癌治療学会学術集会
- Place of Presentation
  パシフィコ横浜(神奈川)
- Year and Date
  2009-10-22
- Data Source
  KAKENHI-PROJECT-21592149
[Presentation] 当科における白金製剤耐性卵巣癌におけるGemcitabine単剤療法の有効性2008
- Author(s)
  佐々木浩, 加藤壮介, 川辺紗智子, 藤岡聡枝, 田中良道, 恒遠啓示, 金村昌徳, 田辺晃子, 寺井義人, 大道正英
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋国際会議場
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] 卵巣癌におけるEGFR遺伝子のmutation、発現とAKT、ERKの活性化の臨床的意義」2008
- Author(s)
  田中良道, 寺井義人, 加藤壮介, 川辺紗智子, 藤岡聡枝, 佐々木浩, 恒遠啓示, 金村昌徳, 田辺晃子, 大道正英
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋国際会議場
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] topoisomerase I inhibitorであるtopotecanはin vivoにおいてcddp耐性を解除するか?2008
- Author(s)
  恒遠啓示, 寺井義人, 金村昌徳, 竹原幹雄, 佐々木浩, 田中良道, 田辺晃子, 大道正英
- Organizer
  第60回日本産科婦人科学会総会・学術講演会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] Topoisomerase 1 inhibitorであるtopotecanのCDDP耐性解除機構2008
- Author(s)
  佐々木浩, 寺井義人, 金村昌徳, 竹原幹雄, 恒遠啓示, 田中良道, 田辺晃子, 大道正英
- Organizer
  第60回日本産科婦人科学会総会・学術講演会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] Topoisomerase 1 inhibitorであるtopotecanのin vivoにおけるCDDP耐性を解除の解明2008
- Author(s)
  恒遠啓示, 寺井義人, 川辺紗智子, 加藤壮介, 藤岡聡枝, 田中良道, 佐々木浩, 金村昌徳, 田辺晃子, 大道正英
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋国際会議場
- Data Source
  KAKENHI-PROJECT-19591946
[Presentation] Epithelial Mesenchymal Transition (EMT) in Endometrial Cancer
- Author(s)
  Tanaka Y, Terai Y, Fujiwara S, Tsunetoh S, Kanemura M, Tanabe A, Ohmichi M.
- Organizer
  第3回アジア婦人科腫瘍学会　第55回日本婦人科腫瘍学会
- Place of Presentation
  ウェスティン都ホテル京都
- Year and Date
  2014-12-13 – 2014-12-15
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、寺井義人、藤原聡枝、田中良道、恒遠啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  日本婦人科癌分子標的研究会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、中村起代子、中村路彦、兪史夏、田中良道、田中智人、佐々木浩、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  日本産科婦人科学会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 婦人科悪性腫瘍に対するTC療法が及ぼす動脈硬化への影響とその予防について
- Author(s)
  渡辺綾子　田辺晃子中井香奈　永易洋子　丸岡理紗　高井雅聡　中村起代子　関島龍治　大道正英
- Organizer
  第66回　日本産科婦人科学会
- Place of Presentation
  東京都　東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24592535
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、田中良道、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第66回日本産科婦人科学会
- Place of Presentation
  東京都　東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-25670709

1. OHMICHI Masahide (10283764)

# of Collaborated Projects: 24 results

# of Collaborated Products: 58 results
2. TERAI Yoshito (90278531)

# of Collaborated Projects: 24 results

# of Collaborated Products: 47 results
3. KANEMURA Masanori (40298782)

# of Collaborated Projects: 16 results

# of Collaborated Products: 33 results
4. TANAKA Yoshimichi (10625502)

# of Collaborated Projects: 16 results

# of Collaborated Products: 22 results
5. HAYASHI Masami (00551748)

# of Collaborated Projects: 15 results

# of Collaborated Products: 4 results
6. SASAKI Hiroshi (80432491)

# of Collaborated Projects: 15 results

# of Collaborated Products: 12 results
7. TSUNETOH Satoshi (70388255)

# of Collaborated Projects: 14 results

# of Collaborated Products: 19 results
8. Fujiwara Satoe (90707960)

# of Collaborated Projects: 8 results

# of Collaborated Products: 1 results
9. Yoo Saha (80625674)

# of Collaborated Projects: 7 results

# of Collaborated Products: 3 results
10. YAMASHITA Yoshiki (50268207)

# of Collaborated Projects: 6 results

# of Collaborated Products: 6 results
11. 田中智人 (90411363)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
12. SAKATA Masahiro (10260639)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
13. TAKEHARA Mikio (40298766)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
14. HAYASHI Atushi (80411338)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
15. KAMEGAI Hideki (30204639)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. TASAKA Keiichi (50155058)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. TAHARA Masahiro (00294091)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. HAYAKAWA Jun (80397736)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. HASHOMOTO Namiko (60379253)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. YAMADA Takashi (10182536)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. ASAHI Michio (10397614)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
22. NAKAMURA Kiyoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
23. Nakagawa Takatoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. Ai Tomohiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

TANABE Akiko 田辺 晃子

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian ToxicityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

TANABE Akiko 田辺晃子